# MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers

> **NCT00563394** · PHASE3 · COMPLETED · sponsor: **Abeona Therapeutics, Inc** · enrollment: 584 (actual)

## Conditions studied

- Diabetic Foot Ulcers

## Interventions

- **DRUG:** ofloxacin
- **DRUG:** MSI-78

## Key facts

- **NCT ID:** NCT00563394
- **Lead sponsor:** Abeona Therapeutics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-08
- **Primary completion:** 1996-07
- **Final completion:** 1996-07
- **Target enrollment:** 584 (ACTUAL)
- **Last updated:** 2020-09-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00563394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00563394, "MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00563394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*